Webinar - Navigating the ABCs of Early Phase CNS Drug and Cannabinoid Development by Dr. Setnik скачать в хорошем качестве

Webinar - Navigating the ABCs of Early Phase CNS Drug and Cannabinoid Development by Dr. Setnik

In this webinar presented by Altasciences' Dr. Beatrice Setnik, Chief Scientific Officer, we explore the evolving requirements for early phase CNS drug and cannabinoid development, including specialty studies, as well as strategic endpoint selection, planning, and budgeting for those studies. Given changing regulations and risk/benefit optimizations, we'll also provide insight on how to successfully navigate the regulatory environment. Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences… helping sponsors get better drugs to the people who need them, faster. Visit our website to learn more: https://www.altasciences.com/